ISR Immune System Regulation Holding AB (publ) 5,20
ISR Immune System Regulation Holding AB (publ) researches and develops drugs for the treatment of viral infections in Sweden. The company's product pipeline includes Covid-19 vaccine, HBV, HIV, and oncology. The company is headquartered in Stockholm, Sweden. Læs mere
Kr. 307M Markedsværdi (Mcap)
- Omsætning
Bioteknologi Industri
Sverige Handles på børsen
israb.se Hjemmeside
Sundhed Sektor